
Prothena Corp PLC is a biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating rare neurodegenerative and peripheral amyloid diseases. The company's clinical pipeline of antibody-based product c... Prothena Corp PLC is a biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating rare neurodegenerative and peripheral amyloid diseases. The company's clinical pipeline of antibody-based product candidates targets a range of indications, including Amyloid Light-chain (AL) amyloidosis (NEOD001), Parkinson's disease and other related synucleinopathies (PRX002), and inflammatory diseases, including psoriasis and psoriatic arthritis (PRX003) and ATTR amyloidosis (PRX004). Show more
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.87 | 16.4772727273 | 5.28 | 6.15 | 4.95 | 1522978 | 5.50251323 | CS |
4 | -1.01 | -14.1061452514 | 7.16 | 7.24 | 4.32 | 2350780 | 5.03486841 | CS |
12 | -6.51 | -51.4218009479 | 12.66 | 13.52 | 4.32 | 1549684 | 6.83889839 | CS |
26 | -7.72 | -55.6596971882 | 13.87 | 17.66 | 4.32 | 991218 | 8.77920193 | CS |
52 | -14.29 | -69.9119373777 | 20.44 | 25.42 | 4.32 | 731595 | 12.10948812 | CS |
156 | -18.49 | -75.0405844156 | 24.64 | 79.65 | 4.32 | 633178 | 32.04618167 | CS |
260 | -3.68 | -37.4364191251 | 9.83 | 79.749 | 4.32 | 533741 | 32.41743426 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.